The Atlantic

The Mothers Who Aren’t Waiting to Give Their Children Cystic-Fibrosis Drugs

At six months pregnant, Sonja Lee Finnegan flew from Switzerland to France to buy $20,000 worth of drugs from a person she had never met. The drug she was after, Trikafta, is legal in Switzerland and ...
The Atlantic

The Cystic-Fibrosis Breakthrough That Changed Everything

They call it the Purge. You have experienced, in a modest way, something like it in the waning days of a bad cold, when your lungs finally expel their accumulated gunk. The rattle in your chest quiets ...
Business Wire

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use ...
The New York Times

The Drug Is a ‘Miracle’ but These Families Can’t Get It

Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit. Shwetha Sree, left, with her 5-year-old son Vihaan, who ...
FiercePharma

Vertex's Trikafta pricing central to cystic fibrosis treatment disparities, study says

The cost of a popular Vertex Pharmaceuticals therapy could be contributing to cystic fibrosis (CF) treatment disparities around the world, researchers argued in a recent paper. Just 12% of some ...
Business Wire

Vertex to Present New Data on its Portfolio of Cystic Fibrosis Medicines at the 2022 North American Cystic Fibrosis Conference

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that multiple abstracts on the company’s portfolio of cystic fibrosis (CF) medicines will be presented in ...
Seeking Alpha

Vertex: Continued Advances In Cystic Fibrosis Market With Expansion Plans

Vertex Pharmaceuticals Incorporated (VRTX) is a good long-term pharmaceutical company to look into. That's because it is already performing well in the Cystic ...
FierceBiotech

UPDATE: Vertex beats own record in cystic fibrosis as next-gen treatment goes up against Trikafta

Set the bar and then beat it; that's what Vertex Pharmaceuticals has just done with a next-gen cystic fibrosis (CF) treatment. The investigational treatment is a once-daily triple CFTR modulator ...
STAT

State Prescription Drug Affordability Boards could end up limiting access to the life-saving cystic fibrosis medication Trikafta

I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic ...
Nasdaq

Vertex announces FDA exands approval for Trikafta

Vertex Pharmaceuticals (VRTX) announced the U.S. Food and Drug Administration has approved the expanded use of Trikafta for the treatment of people with cystic fibrosis ages 2 and older who have at ...
Nasdaq

Vertex Announces Reimbursement Agreement in Australia for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for Patients With Cystic Fibrosis Ages 12 Years and Older ...

- With this reimbursement agreement in place, more than 2,200 people with CF will have PBS-funded access to TRIKAFTA®, including more than 700 who will now have access to a CFTR modulator therapy for ...